SlideShare a Scribd company logo
1 of 57
Polyps and Prevention: The Importance of
Screening for Colorectal Cancer
TODAY’S WEBINAR
 SPEAKER(S)
 Folasade May, M.D., Ph.D., M.Phil.
 QUESTIONS
 Ask a question in the panel on the RIGHT SIDE of your
screen
 WEBINAR ARCHIVE
 FightCRC.org/webinar
 TWEET ALONG
 Follow along via Twitter – use the hashtag #CRCWebinar
RESOURCES
TABOO-TY PODCAST MINI MAGAZINES CLINICAL TRIAL FINDER
FIGHTCOLORECTALCANCERDISCLAIMER
The information and services provided
by Fight Colorectal Cancer are for
general informational purposes only.
The information and services are not
intended to be substitutes for
professional medical advice,
diagnoses or treatment.
If you are ill, or suspect that you are ill,
see a doctor immediately. In an
emergency, call 911 or go to the
nearest emergency room.
Fight Colorectal Cancer never
recommends or endorses any specific
physicians, products or treatments for
any condition.
Dr.FolaMay Dr. May graduated cum laude from Yale University with a degree in molecular,
cellular, and developmental biology. After college, she attended the University
of Cambridge to study epidemiology and international health, earning a
master’s of philosophy before returning to the States to attend Harvard Medical
School.
Dr. May came to UCLA in 2011 to begin her gastroenterology fellowship. As a
fellow in the UCLA Specialty Training and Advanced Research (STAR) program,
she earned a PhD in health policy and management from the UCLA Fielding
School of Public Health. Her doctoral dissertation addressed black-white
disparities in colorectal cancer incidence, screening, and outcomes.
Dr. May joined the digestive diseases faculty at UCLA as a clinical instructor of
medicine in 2015. She is a member of the UCLA Jonsson Comprehensive Cancer
Center (JCCC) and research collaborator at the UCLA Center for Cancer
Prevention Control Research (CPCR). Her research focuses on eliminating
patient, provider, and system-level barriers to colorectal cancer screening in
Federally Qualified Health Centers and in the Veterans Health Administration.
She is also faculty at the UCLA Center for World Health as co-director for the
Global Health Education Program in the David Geffen School of Medicine. She
has participated in global health programs in Costa Rica, Nigeria, South Africa,
Uganda, Malawi and Tanzania.
drfolamay
Polyps and Prevention:
The Importance of Screening for Colorectal Cancer
Fola May, MD, PhD
Vatche &Tamar Manoukian Division of Digestive Diseases at UCLA
Greater Los AngelesVeterans Health Affairs
UCLA Cancer Prevention Control Research
drfolamay
Colon cancer is common
American Cancer Society, Inc., 2018.
#3 cause of cancer in men and women in the United States
drfolamay
Colon cancer is deadly
#2 cause of cancer-related deaths in the United States
American Cancer Society, Inc., 2018.
What we will cover today
• How does colon cancer start?
• What is a colon polyp?
• How do we prevent colon cancer?
• When should I start screening?
• What are my screening test options?
• How do I become a champion for colon cancer screening?
• What is the role of diet and lifestyle in colon cancer risk?
drfolamay
drfolamay
“Colon Cancer”
=“Colorectal Cancer”
=Cancer that develops in the colon
and/or rectum
drfolamay
drfolamay
What’s the colon for anyway?
The colon and rectum:
• Large intestine or large bowel
• Last parts of the digestive system
The colon functions to:
• Absorb water and salt from food
• Form stool
The rectum functions to:
• Store stool until ready to pass
drfolamay
What is a polyp?
A Polyp is a lump or growth of abnormal
cells
drfolamay
How does colon cancer develop?
Normal Colon Polyp Colon Cancer
Colon cancer develops when the cells in polyps
begin to grow uncontrollably.
years & years & years
drfolamay
Many types of colon polyps
Not pre-cancerous
Mucosal polyps
Inflammatory Pseudopolyps
Submucosal polyps
Hamartomatous polyps
May be pre-cancerous
Sessile serrated polyps
Sessile serrated adenomas
Traditional sessile adenoma
Tubular adenomas
drfolamay
Adenomatous polyps
• Source of the majority of colon cancers
• ≤ 5% will progress to CRC (over ~7 to 10 years)
• Require more frequent screening if considered ”advanced”:
• ≥ 1 centimeter in diameter
• Microscope exam reveals “tubulo-villous” features or “high grade
dysplasia”
drfolamay
• Red or black blood
• Change in stool shape
• Cramping or discomfort
• Urge to have a bowel
movement
• New constipation or
diarrhea
• Decreased appetite
• Unintentional weight loss
But by the time these
symptoms occur, the cancer
can be advanced
Precancerous polyps and early colon cancer do not cause symptoms.
As a polyp grows, it can bleed into the stool or cause a blockage in the intestine, which may
cause symptoms of colon cancer:
Do not wait for symptoms
So how do we prevent polyps from
becoming cancer?
drfolamay
drfolamay
Colon cancer screening
• Screening tests allow us to detect and
remove colon polyps before they become
cancer.
• Screening tests also detect colon cancers
early and before they cause symptoms.
Age to start screening
drfolamay
Those with a family history
Family History American Cancer
Society
American College
of
Gastroenterology
First degree relative
with colon cancer or
colon polyps
(mother, father, sister,
brother)
Colonoscopy at age 40
Repeat every 5 years
Colonoscopy at age 40
-OR-
10 years younger than
diagnosis age of the
youngest affected relative
Repeat every 5 years
drfolamay
Higher risk groups
Crohn’s disease
Ulcerative colitis
Familial polyposis syndromes
Hereditary colon cancer
Screen early (age varies);
Often repeated annually
African-Americans*
Begin screening at age 45
(Screen with colonoscopy)
*American College of Gastroenterology recommendation
drfolamay
“Average risk” individuals
U.S. Preventive Task
Force
American Cancer
Society
Start at age 50
Screen until at least age 75
(Consider screening till age 85)
Start at age 45
Screen until age 75
drfolamay
Ahnen et al. Mayo Clin Proc, 2014.
Age > 50 Age < 50
45 or 50?
drfolamay
Pros and cons for screening at 45
Motivations
• Rising incidence in age <50
• No current efforts in age < 50
• May boost screening overall
Potential Shortcomings
• No strong data to support
• Possible diversion of resources
• Additional 21 million to screen
between age 45-49
• May widen inequities in screening
• Cost
• Insurance coverage
Liang et al, Gastro, 2018.
Imperiale et al, CGH, 2018.
Screening modalities
drfolamay
gFOBT
CT Colonography
Fecal Immunochemical
Test (FIT)
FIT-DNA
(Cologuard)
Stool-based strategies
Direct-visualization techniques
Flexible Sigmoidoscopy Colonoscopy
Screening tests
Serology
Capsule
drfolamay
Colonoscopy
• Performed in a hospital or medical clinic
• Requires bowel preparation
• Gastroenterologist uses a “colonoscope,” a long flexible tube
with a light at the end
• Requires conscious sedation or monitored anesthesia care
• Examines the walls of the colon (20-30 minutes)
• Risks are very small (1:1000) and include bleeding, infection,
and colon injury
• Considered the gold standard for finding colon cancer or
precancerous polyps
• If normal, repeated every 10 years
drfolamay
A proper colon prep is key!
drfolamay
Polyps can be hard to see
drfolamay
Barriers to screening colonoscopy
Embarrassment
Fear of discomfort
Time off Work
Insurance
Concerns about Prep
Access to endoscopist
Fear of Sedation
Out of pocket costs
Need for escort
drfolamay
Fecal immunochemical test (FIT)
• Second most common screening test
• Stool-based test that can be performed at home
• Tests the stool for small amounts of human blood
which may be a sign of colon cancer
• Low-risk screening option
• Performed yearly to be effective
• Two-step screening process
drfolamay
Abnormal follow-up after positive FIT
Positive FIT
Result
Must have
colonoscopy
drfolamay
Abnormal follow-up after positive FIT
Up to 1 in 3 with abnormal FIT have a large
polyp or colon cancer.
Up to 1 in 10 with abnormal FIT have colon
cancer.
drfolamay
gFOBT
CT Colonography
Fecal Immunochemical
Test (FIT)
FIT-DNA
(Cologuard)
Flexible Sigmoidoscopy Colonoscopy
Serology
Capsule
drfolamay
• Tests stool for 11 pre-cancer and cancer biomarkers
• Includes test for human hemoglobin (i.e. DNA+FIT)
• 3-year screening interval (proposed)
• Limitations:
• Very few studies
• No data to support 3-year interval
• High false positive rate
• High failure to complete rate
• Not always covered by insurance
Multitarget stool DNA (Cologuard)
drfolamay
gFOBT
CT Colonography
Fecal Immunochemical
Test (FIT)
FIT-DNA
(Cologuard)
Flexible Sigmoidoscopy Colonoscopy
Serology
Capsule
drfolamay
gFOBT
CT Colonography
Fecal Immunochemical
Test (FIT)
FIT-DNA
(Cologuard)
Flexible Sigmoidoscopy Colonoscopy
Serology
Capsule
drfolamay
CT Colonography
• CT or “CAT Scan” that provides a 2-D and 3-D image of the colon.
• Requires a bowel preparation and insufflation with air or carbon
dioxide.
• Requires colonoscopy if polyps are found
• Does not detect small polyps well
• May result in further unnecessary testing and costs due to
unexpected findings (25%-80% cases).
drfolamay
gFOBT
CT Colonography
Fecal Immunochemical
Test (FIT)
FIT-DNA
(Cologuard)
Flexible Sigmoidoscopy Colonoscopy
Serology
Capsule
drfolamay
“First Tier” tests
Colonoscopy
Every 10 years
Fecal Immunochemical
Test (FIT) annually
MSTF. 2018.
drfolamay
Despite strong evidence for screening and
guidelines,
one in three Americans is unscreened
drfolamay
Behavioral Risk Factor
Surveillance System
(BRFSS), 2012.
Screening* (%) Among US Adults Age 50-75
Colorectal cancer screening uptake
PercentPopulationScreened
Year
37.1%
55.0%
64.5%
65.1%
66.2%
67.3%
Patient-Level Factors
Knowledge
Beliefs
Health Literacy
Education
Income
Insurance
Access to care
Comorbidity
Cancer fatalism
Fear
Provider-Level Factors
Health care setting
Knowledge of guidelines
Practices
Recommendation to screen
System-Level Factors
Reminder systems
Access to providers
Colonoscopy capacity
Care coordination Smedley et al. IOM, 2003.
So why is screening so difficult?
drfolamay
National campaign to increase screening
• National Colorectal Cancer Roundtable campaign
• In 2014, established goal of ”80% by 2018”
• Endorsed by over 700 organizations & institutions
• Renewed in 2018 as “80% in every community”
• Targeted efforts and funding to improve screening in low participation
populations
drfolamay
Rates decreasing over time
Surveillance, Epidemiology, and End
Results Program 9; 1975-2013.
drfolamay
Improving from here
• Increase participation in screening
• Know your family history
• “Surveillance” for individuals with polyps
• Follow screening intervals
• Survivors need to continue colonoscopies
• Year 1  Year 4  Year 9
drfolamay
Colonoscopy for survivors
Kahi et al. AJG. 2016.
Colorectal
cancer
diagnosis
Colonoscopy before
surgery
(or 3-6 mo post)
Colonoscopy at 1
year
Surgical
resection
Colonoscopy 3
years later
Colonoscopy
every 5 years
*If rectal cancer: May need rectal ultrasound every 3-6
months as well (2-3 years)
drfolamay
drfolamay
And are there additional ways to
minimize risk?
drfolamay
Colon cancer risk factors
Risk Factors You Can Change
• Diet
• Physical inactivity
• Obesity
• Type 2 diabetes
• Tobacco use
• Heavy alcohol use
Risk Factors You Can Not Change
• Age
• Male gender
• Race (African-Americans)
• Personal history of polyps
• Family history of polyps or cancer
• Inflammatory bowel disease (IBD)
• Inherited polyp syndromes
drfolamay
Modifying your diet
• Minimize processed meats:
• Ham, bacon, hot dogs, raw sausages (salami), bologna,
blood sausage, pate, meat spreads, cold cuts, canned
meats, corned beef
• Minimize red meats:
• Beef, pork, lamb, goat
• Increase intake of:
• Whole grains, fiber, fruit, non-starchy vegetables, vitamin
C-rich foods, fish, vitamin D
Slide credit: UCLA Digestive Health
Nutrition Program
drfolamay
Other lifestyle changes
• Increase physical activity
• Drink alcohol in moderation
• Maximum of 2 drinks/day for men; 1 drink/day for women
• Maximum 14 units/week for men and women
• Avoid tobacco
In summary
• Screening for colon cancer is effective
• Screening works by removing polyps and finding cancers early
• There are many effective screening options so pick the one that is
best for you
• We can all help educate family and loved ones about colon cancer
risk and screening
drfolamay
drfolamay
Thank You!
Q
&
A
SNAP A #STRONGARMSELFIE
In 2018, up to $55,000 will be donated thanks to our
sponsors: Bayer, Fujifilm, Myriad Genetics and Taiho
Oncology!
Flex a “strong arm” & post it to Twitter or Instagram using the
hashtag #StrongArmSelfie
CONTACT US
CALL TOLL FREE
1.877.427.2111

More Related Content

What's hot

Gastrointestinal stromal tumors
Gastrointestinal stromal tumorsGastrointestinal stromal tumors
Gastrointestinal stromal tumorsMW Castro Mollo
 
Cancer of unknown primary: Knowing the unknown
Cancer of unknown primary: Knowing the unknownCancer of unknown primary: Knowing the unknown
Cancer of unknown primary: Knowing the unknownMary Ondinee Manalo Igot
 
Locoregional therapy for HCC
Locoregional therapy for HCCLocoregional therapy for HCC
Locoregional therapy for HCCPratap Tiwari
 
Oncotype dx presentation
Oncotype dx presentationOncotype dx presentation
Oncotype dx presentationahmed mjali
 
CES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancerCES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancerMauricio Lema
 
Breast cancer epidemiology
Breast cancer epidemiology Breast cancer epidemiology
Breast cancer epidemiology abdulaziz muslim
 
Opportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and PreventionOpportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and Preventionbkling
 
Systemic therapy stage 4 breast sadia
Systemic therapy stage 4 breast sadiaSystemic therapy stage 4 breast sadia
Systemic therapy stage 4 breast sadiaSadia Sadiq
 
Satyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancerSatyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancerSatyajeet Rath
 
Principles of oncology
Principles of oncologyPrinciples of oncology
Principles of oncologysurgerymgmcri
 
Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Mohamed Abdulla
 
Carcinoma esophagus
Carcinoma esophagusCarcinoma esophagus
Carcinoma esophagusmanu tiwari
 

What's hot (20)

Gastrointestinal stromal tumors
Gastrointestinal stromal tumorsGastrointestinal stromal tumors
Gastrointestinal stromal tumors
 
Prostate Cancer 2013
Prostate Cancer 2013Prostate Cancer 2013
Prostate Cancer 2013
 
Lung Cancer - Rivin
Lung Cancer - RivinLung Cancer - Rivin
Lung Cancer - Rivin
 
Total Neoadjuvant therapy in locally advanced carcinoma Rectum
Total Neoadjuvant therapy in locally advanced carcinoma RectumTotal Neoadjuvant therapy in locally advanced carcinoma Rectum
Total Neoadjuvant therapy in locally advanced carcinoma Rectum
 
Cancer of unknown primary: Knowing the unknown
Cancer of unknown primary: Knowing the unknownCancer of unknown primary: Knowing the unknown
Cancer of unknown primary: Knowing the unknown
 
Locoregional therapy for HCC
Locoregional therapy for HCCLocoregional therapy for HCC
Locoregional therapy for HCC
 
Oncotype dx presentation
Oncotype dx presentationOncotype dx presentation
Oncotype dx presentation
 
CES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancerCES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancer
 
Trials in esophageal cancer.pptx
Trials in esophageal cancer.pptxTrials in esophageal cancer.pptx
Trials in esophageal cancer.pptx
 
Colon cancer
Colon cancerColon cancer
Colon cancer
 
Breast cancer epidemiology
Breast cancer epidemiology Breast cancer epidemiology
Breast cancer epidemiology
 
Ca prostate
Ca prostateCa prostate
Ca prostate
 
Opportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and PreventionOpportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and Prevention
 
Management of Rectal Carcinoma
Management of Rectal Carcinoma Management of Rectal Carcinoma
Management of Rectal Carcinoma
 
Systemic therapy stage 4 breast sadia
Systemic therapy stage 4 breast sadiaSystemic therapy stage 4 breast sadia
Systemic therapy stage 4 breast sadia
 
Satyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancerSatyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancer
 
Principles of oncology
Principles of oncologyPrinciples of oncology
Principles of oncology
 
Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015
 
Carcinoma esophagus
Carcinoma esophagusCarcinoma esophagus
Carcinoma esophagus
 
ADRENAL INCDIENTALOMA
ADRENAL INCDIENTALOMAADRENAL INCDIENTALOMA
ADRENAL INCDIENTALOMA
 

Similar to March 2019 - Polyps and Prevention: The Importance of Screening for Colorectal Cancer Webinar

Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women vandana bansal
 
Global Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVES
Global Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVESGlobal Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVES
Global Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVESGlobal Medical Cures™
 
Nov. Webinar - Research Update: advanced adenomas among first degree relative...
Nov. Webinar - Research Update: advanced adenomas among first degree relative...Nov. Webinar - Research Update: advanced adenomas among first degree relative...
Nov. Webinar - Research Update: advanced adenomas among first degree relative...Fight Colorectal Cancer
 
Demystifying Gynecologic Cancer Screenings
Demystifying Gynecologic Cancer ScreeningsDemystifying Gynecologic Cancer Screenings
Demystifying Gynecologic Cancer ScreeningsPennMedicine
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awarenessdrmcbansal
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness drmcbansal
 
Cancer Prevention Presentxxxxxxation.pdf
Cancer Prevention Presentxxxxxxation.pdfCancer Prevention Presentxxxxxxation.pdf
Cancer Prevention Presentxxxxxxation.pdfshubham732937
 
Colorectal Cancer 101- Research Advocacy Training Webinar
Colorectal Cancer 101- Research Advocacy Training WebinarColorectal Cancer 101- Research Advocacy Training Webinar
Colorectal Cancer 101- Research Advocacy Training WebinarFight Colorectal Cancer
 
Do not die of colon cancer press message 2
Do not die  of colon cancer press message 2Do not die  of colon cancer press message 2
Do not die of colon cancer press message 2Innocent Atuhe
 
screening of cancers
screening of cancersscreening of cancers
screening of cancersShodhan Patel
 
Defeating colorectal cancer
Defeating colorectal cancerDefeating colorectal cancer
Defeating colorectal cancerRONALDO QUITCO
 

Similar to March 2019 - Polyps and Prevention: The Importance of Screening for Colorectal Cancer Webinar (20)

Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
 
Global Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVES
Global Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVESGlobal Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVES
Global Medical Cures™ | COLORECTAL CANCER SCREENING SAVES LIVES
 
Nov. Webinar - Research Update: advanced adenomas among first degree relative...
Nov. Webinar - Research Update: advanced adenomas among first degree relative...Nov. Webinar - Research Update: advanced adenomas among first degree relative...
Nov. Webinar - Research Update: advanced adenomas among first degree relative...
 
Colon Cancer
Colon CancerColon Cancer
Colon Cancer
 
Cancer Facts for People Over 50
Cancer Facts for People Over 50Cancer Facts for People Over 50
Cancer Facts for People Over 50
 
Demystifying Gynecologic Cancer Screenings
Demystifying Gynecologic Cancer ScreeningsDemystifying Gynecologic Cancer Screenings
Demystifying Gynecologic Cancer Screenings
 
Colorectal cancer
Colorectal cancer Colorectal cancer
Colorectal cancer
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awareness
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness
 
Cancer Prevention Presentxxxxxxation.pdf
Cancer Prevention Presentxxxxxxation.pdfCancer Prevention Presentxxxxxxation.pdf
Cancer Prevention Presentxxxxxxation.pdf
 
Cancer Screening in the Normal Risk 2018
Cancer Screening in the Normal Risk 2018Cancer Screening in the Normal Risk 2018
Cancer Screening in the Normal Risk 2018
 
Colorectal Cancer 101- Research Advocacy Training Webinar
Colorectal Cancer 101- Research Advocacy Training WebinarColorectal Cancer 101- Research Advocacy Training Webinar
Colorectal Cancer 101- Research Advocacy Training Webinar
 
Women cancer
Women cancerWomen cancer
Women cancer
 
mati
matimati
mati
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
 
Do not die of colon cancer press message 2
Do not die  of colon cancer press message 2Do not die  of colon cancer press message 2
Do not die of colon cancer press message 2
 
screening of cancers
screening of cancersscreening of cancers
screening of cancers
 
Defeating colorectal cancer
Defeating colorectal cancerDefeating colorectal cancer
Defeating colorectal cancer
 
Tcu 2014
Tcu 2014Tcu 2014
Tcu 2014
 
Cancer a silent killer
Cancer a silent killerCancer a silent killer
Cancer a silent killer
 

More from Fight Colorectal Cancer

Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Fight Colorectal Cancer
 
Managing the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerManaging the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerFight Colorectal Cancer
 
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNABiomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNAFight Colorectal Cancer
 
Coping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisCoping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisFight Colorectal Cancer
 
Colorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarColorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarFight Colorectal Cancer
 
Research Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarResearch Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarFight Colorectal Cancer
 
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarMay 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarFight Colorectal Cancer
 

More from Fight Colorectal Cancer (20)

Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.
 
August 2020 Webinar Slides
August 2020 Webinar SlidesAugust 2020 Webinar Slides
August 2020 Webinar Slides
 
July 2020 webinar slides
July 2020 webinar slidesJuly 2020 webinar slides
July 2020 webinar slides
 
Managing the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerManaging the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal Cancer
 
Maine’s CRC Policy Story
Maine’s CRC Policy StoryMaine’s CRC Policy Story
Maine’s CRC Policy Story
 
Indiana’s CRC Policy Story
Indiana’s CRC Policy StoryIndiana’s CRC Policy Story
Indiana’s CRC Policy Story
 
Kentucky’s CRC Policy Story Webinar
Kentucky’s CRC Policy Story WebinarKentucky’s CRC Policy Story Webinar
Kentucky’s CRC Policy Story Webinar
 
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNABiomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
 
Coping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisCoping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer Diagnosis
 
Colorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarColorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinar
 
GI ASCO 2020 Recap Webinar
GI ASCO 2020 Recap WebinarGI ASCO 2020 Recap Webinar
GI ASCO 2020 Recap Webinar
 
Conversations About End-of-Life Webinar
Conversations About End-of-Life WebinarConversations About End-of-Life Webinar
Conversations About End-of-Life Webinar
 
Clinical Trial Finder Webinar
Clinical Trial Finder WebinarClinical Trial Finder Webinar
Clinical Trial Finder Webinar
 
Palliative Care 101 Webinar
Palliative Care 101 WebinarPalliative Care 101 Webinar
Palliative Care 101 Webinar
 
Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar
 
August 2019 - Recurrence: What now?
August 2019 - Recurrence: What now?August 2019 - Recurrence: What now?
August 2019 - Recurrence: What now?
 
Research Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarResearch Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer Webinar
 
Post ASCO Webinar 2019
Post ASCO Webinar 2019Post ASCO Webinar 2019
Post ASCO Webinar 2019
 
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarMay 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
 
May 2019 – Cancer and Trauma Webinar
May 2019 – Cancer and Trauma Webinar May 2019 – Cancer and Trauma Webinar
May 2019 – Cancer and Trauma Webinar
 

Recently uploaded

ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.Christina Parmionova
 
Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...
Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...
Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...Amil baba
 
2024 ECOSOC YOUTH FORUM -logistical information - United Nations Economic an...
2024 ECOSOC YOUTH FORUM -logistical information -  United Nations Economic an...2024 ECOSOC YOUTH FORUM -logistical information -  United Nations Economic an...
2024 ECOSOC YOUTH FORUM -logistical information - United Nations Economic an...Christina Parmionova
 
Press Freedom in Europe - Time to turn the tide.
Press Freedom in Europe - Time to turn the tide.Press Freedom in Europe - Time to turn the tide.
Press Freedom in Europe - Time to turn the tide.Christina Parmionova
 
PEO AVRIL POUR LA COMMUNE D'ORGERUS INFO
PEO AVRIL POUR LA COMMUNE D'ORGERUS INFOPEO AVRIL POUR LA COMMUNE D'ORGERUS INFO
PEO AVRIL POUR LA COMMUNE D'ORGERUS INFOMAIRIEORGERUS
 
Build Tomorrow’s India Today By Making Charity For Poor Students
Build Tomorrow’s India Today By Making Charity For Poor StudentsBuild Tomorrow’s India Today By Making Charity For Poor Students
Build Tomorrow’s India Today By Making Charity For Poor StudentsSERUDS INDIA
 
NL-FR Partnership - Water management roundtable 20240403.pdf
NL-FR Partnership - Water management roundtable 20240403.pdfNL-FR Partnership - Water management roundtable 20240403.pdf
NL-FR Partnership - Water management roundtable 20240403.pdfBertrand Coppin
 
ISEIDP in Chikkaballapura, Karnataka, India
ISEIDP in Chikkaballapura, Karnataka, IndiaISEIDP in Chikkaballapura, Karnataka, India
ISEIDP in Chikkaballapura, Karnataka, IndiaTrinity Care Foundation
 
If there is a Hell on Earth, it is the Lives of Children in Gaza.pdf
If there is a Hell on Earth, it is the Lives of Children in Gaza.pdfIf there is a Hell on Earth, it is the Lives of Children in Gaza.pdf
If there is a Hell on Earth, it is the Lives of Children in Gaza.pdfKatrina Sriranpong
 
2023 Ecological Profile of Ilocos Norte.pdf
2023 Ecological Profile of Ilocos Norte.pdf2023 Ecological Profile of Ilocos Norte.pdf
2023 Ecological Profile of Ilocos Norte.pdfilocosnortegovph
 
Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...
Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...
Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...MartMantilla1
 
UN DESA: Finance for Development 2024 Report
UN DESA: Finance for Development 2024 ReportUN DESA: Finance for Development 2024 Report
UN DESA: Finance for Development 2024 ReportEnergy for One World
 
Digital Transformation of the Heritage Sector and its Practical Implications
Digital Transformation of the Heritage Sector and its Practical ImplicationsDigital Transformation of the Heritage Sector and its Practical Implications
Digital Transformation of the Heritage Sector and its Practical ImplicationsBeat Estermann
 
2024: The FAR, Federal Acquisition Regulations - Part 23
2024: The FAR, Federal Acquisition Regulations - Part 232024: The FAR, Federal Acquisition Regulations - Part 23
2024: The FAR, Federal Acquisition Regulations - Part 23JSchaus & Associates
 
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.Christina Parmionova
 
European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...
European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...
European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...Energy for One World
 
2024: The FAR, Federal Acquisition Regulations - Part 24
2024: The FAR, Federal Acquisition Regulations - Part 242024: The FAR, Federal Acquisition Regulations - Part 24
2024: The FAR, Federal Acquisition Regulations - Part 24JSchaus & Associates
 
NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...
NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...
NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...Amil Baba Dawood bangali
 
Pope Francis Teaching: Dignitas Infinita- On Human Dignity
Pope Francis Teaching: Dignitas Infinita- On Human DignityPope Francis Teaching: Dignitas Infinita- On Human Dignity
Pope Francis Teaching: Dignitas Infinita- On Human DignityEnergy for One World
 

Recently uploaded (20)

ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -17 April.
 
Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...
Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...
Uk-NO1 Black magic Specialist Expert in Uk Usa Uae London Canada England Amer...
 
2024 ECOSOC YOUTH FORUM -logistical information - United Nations Economic an...
2024 ECOSOC YOUTH FORUM -logistical information -  United Nations Economic an...2024 ECOSOC YOUTH FORUM -logistical information -  United Nations Economic an...
2024 ECOSOC YOUTH FORUM -logistical information - United Nations Economic an...
 
Press Freedom in Europe - Time to turn the tide.
Press Freedom in Europe - Time to turn the tide.Press Freedom in Europe - Time to turn the tide.
Press Freedom in Europe - Time to turn the tide.
 
PEO AVRIL POUR LA COMMUNE D'ORGERUS INFO
PEO AVRIL POUR LA COMMUNE D'ORGERUS INFOPEO AVRIL POUR LA COMMUNE D'ORGERUS INFO
PEO AVRIL POUR LA COMMUNE D'ORGERUS INFO
 
Build Tomorrow’s India Today By Making Charity For Poor Students
Build Tomorrow’s India Today By Making Charity For Poor StudentsBuild Tomorrow’s India Today By Making Charity For Poor Students
Build Tomorrow’s India Today By Making Charity For Poor Students
 
Housing For All - Fair Housing Choice Report
Housing For All - Fair Housing Choice ReportHousing For All - Fair Housing Choice Report
Housing For All - Fair Housing Choice Report
 
NL-FR Partnership - Water management roundtable 20240403.pdf
NL-FR Partnership - Water management roundtable 20240403.pdfNL-FR Partnership - Water management roundtable 20240403.pdf
NL-FR Partnership - Water management roundtable 20240403.pdf
 
ISEIDP in Chikkaballapura, Karnataka, India
ISEIDP in Chikkaballapura, Karnataka, IndiaISEIDP in Chikkaballapura, Karnataka, India
ISEIDP in Chikkaballapura, Karnataka, India
 
If there is a Hell on Earth, it is the Lives of Children in Gaza.pdf
If there is a Hell on Earth, it is the Lives of Children in Gaza.pdfIf there is a Hell on Earth, it is the Lives of Children in Gaza.pdf
If there is a Hell on Earth, it is the Lives of Children in Gaza.pdf
 
2023 Ecological Profile of Ilocos Norte.pdf
2023 Ecological Profile of Ilocos Norte.pdf2023 Ecological Profile of Ilocos Norte.pdf
2023 Ecological Profile of Ilocos Norte.pdf
 
Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...
Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...
Republic Act 11032 (Ease of Doing Business and Efficient Government Service D...
 
UN DESA: Finance for Development 2024 Report
UN DESA: Finance for Development 2024 ReportUN DESA: Finance for Development 2024 Report
UN DESA: Finance for Development 2024 Report
 
Digital Transformation of the Heritage Sector and its Practical Implications
Digital Transformation of the Heritage Sector and its Practical ImplicationsDigital Transformation of the Heritage Sector and its Practical Implications
Digital Transformation of the Heritage Sector and its Practical Implications
 
2024: The FAR, Federal Acquisition Regulations - Part 23
2024: The FAR, Federal Acquisition Regulations - Part 232024: The FAR, Federal Acquisition Regulations - Part 23
2024: The FAR, Federal Acquisition Regulations - Part 23
 
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.
ECOSOC YOUTH FORUM 2024 - Side Events Schedule -16 April.
 
European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...
European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...
European Court of Human Rights: Judgment Verein KlimaSeniorinnen Schweiz and ...
 
2024: The FAR, Federal Acquisition Regulations - Part 24
2024: The FAR, Federal Acquisition Regulations - Part 242024: The FAR, Federal Acquisition Regulations - Part 24
2024: The FAR, Federal Acquisition Regulations - Part 24
 
NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...
NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...
NO1 Certified Best vashikaran specialist in UK USA UAE London Dubai Canada Am...
 
Pope Francis Teaching: Dignitas Infinita- On Human Dignity
Pope Francis Teaching: Dignitas Infinita- On Human DignityPope Francis Teaching: Dignitas Infinita- On Human Dignity
Pope Francis Teaching: Dignitas Infinita- On Human Dignity
 

March 2019 - Polyps and Prevention: The Importance of Screening for Colorectal Cancer Webinar

  • 1. Polyps and Prevention: The Importance of Screening for Colorectal Cancer
  • 2. TODAY’S WEBINAR  SPEAKER(S)  Folasade May, M.D., Ph.D., M.Phil.  QUESTIONS  Ask a question in the panel on the RIGHT SIDE of your screen  WEBINAR ARCHIVE  FightCRC.org/webinar  TWEET ALONG  Follow along via Twitter – use the hashtag #CRCWebinar
  • 3. RESOURCES TABOO-TY PODCAST MINI MAGAZINES CLINICAL TRIAL FINDER
  • 4. FIGHTCOLORECTALCANCERDISCLAIMER The information and services provided by Fight Colorectal Cancer are for general informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnoses or treatment. If you are ill, or suspect that you are ill, see a doctor immediately. In an emergency, call 911 or go to the nearest emergency room. Fight Colorectal Cancer never recommends or endorses any specific physicians, products or treatments for any condition.
  • 5. Dr.FolaMay Dr. May graduated cum laude from Yale University with a degree in molecular, cellular, and developmental biology. After college, she attended the University of Cambridge to study epidemiology and international health, earning a master’s of philosophy before returning to the States to attend Harvard Medical School. Dr. May came to UCLA in 2011 to begin her gastroenterology fellowship. As a fellow in the UCLA Specialty Training and Advanced Research (STAR) program, she earned a PhD in health policy and management from the UCLA Fielding School of Public Health. Her doctoral dissertation addressed black-white disparities in colorectal cancer incidence, screening, and outcomes. Dr. May joined the digestive diseases faculty at UCLA as a clinical instructor of medicine in 2015. She is a member of the UCLA Jonsson Comprehensive Cancer Center (JCCC) and research collaborator at the UCLA Center for Cancer Prevention Control Research (CPCR). Her research focuses on eliminating patient, provider, and system-level barriers to colorectal cancer screening in Federally Qualified Health Centers and in the Veterans Health Administration. She is also faculty at the UCLA Center for World Health as co-director for the Global Health Education Program in the David Geffen School of Medicine. She has participated in global health programs in Costa Rica, Nigeria, South Africa, Uganda, Malawi and Tanzania.
  • 6. drfolamay Polyps and Prevention: The Importance of Screening for Colorectal Cancer Fola May, MD, PhD Vatche &Tamar Manoukian Division of Digestive Diseases at UCLA Greater Los AngelesVeterans Health Affairs UCLA Cancer Prevention Control Research
  • 7. drfolamay Colon cancer is common American Cancer Society, Inc., 2018. #3 cause of cancer in men and women in the United States
  • 8. drfolamay Colon cancer is deadly #2 cause of cancer-related deaths in the United States American Cancer Society, Inc., 2018.
  • 9. What we will cover today • How does colon cancer start? • What is a colon polyp? • How do we prevent colon cancer? • When should I start screening? • What are my screening test options? • How do I become a champion for colon cancer screening? • What is the role of diet and lifestyle in colon cancer risk? drfolamay
  • 10. drfolamay “Colon Cancer” =“Colorectal Cancer” =Cancer that develops in the colon and/or rectum
  • 12. drfolamay What’s the colon for anyway? The colon and rectum: • Large intestine or large bowel • Last parts of the digestive system The colon functions to: • Absorb water and salt from food • Form stool The rectum functions to: • Store stool until ready to pass
  • 13. drfolamay What is a polyp? A Polyp is a lump or growth of abnormal cells
  • 14. drfolamay How does colon cancer develop? Normal Colon Polyp Colon Cancer Colon cancer develops when the cells in polyps begin to grow uncontrollably. years & years & years
  • 15. drfolamay Many types of colon polyps Not pre-cancerous Mucosal polyps Inflammatory Pseudopolyps Submucosal polyps Hamartomatous polyps May be pre-cancerous Sessile serrated polyps Sessile serrated adenomas Traditional sessile adenoma Tubular adenomas
  • 16. drfolamay Adenomatous polyps • Source of the majority of colon cancers • ≤ 5% will progress to CRC (over ~7 to 10 years) • Require more frequent screening if considered ”advanced”: • ≥ 1 centimeter in diameter • Microscope exam reveals “tubulo-villous” features or “high grade dysplasia”
  • 17. drfolamay • Red or black blood • Change in stool shape • Cramping or discomfort • Urge to have a bowel movement • New constipation or diarrhea • Decreased appetite • Unintentional weight loss But by the time these symptoms occur, the cancer can be advanced Precancerous polyps and early colon cancer do not cause symptoms. As a polyp grows, it can bleed into the stool or cause a blockage in the intestine, which may cause symptoms of colon cancer: Do not wait for symptoms
  • 18. So how do we prevent polyps from becoming cancer? drfolamay
  • 19. drfolamay Colon cancer screening • Screening tests allow us to detect and remove colon polyps before they become cancer. • Screening tests also detect colon cancers early and before they cause symptoms.
  • 20. Age to start screening
  • 21. drfolamay Those with a family history Family History American Cancer Society American College of Gastroenterology First degree relative with colon cancer or colon polyps (mother, father, sister, brother) Colonoscopy at age 40 Repeat every 5 years Colonoscopy at age 40 -OR- 10 years younger than diagnosis age of the youngest affected relative Repeat every 5 years
  • 22. drfolamay Higher risk groups Crohn’s disease Ulcerative colitis Familial polyposis syndromes Hereditary colon cancer Screen early (age varies); Often repeated annually African-Americans* Begin screening at age 45 (Screen with colonoscopy) *American College of Gastroenterology recommendation
  • 23. drfolamay “Average risk” individuals U.S. Preventive Task Force American Cancer Society Start at age 50 Screen until at least age 75 (Consider screening till age 85) Start at age 45 Screen until age 75
  • 24. drfolamay Ahnen et al. Mayo Clin Proc, 2014. Age > 50 Age < 50 45 or 50?
  • 25. drfolamay Pros and cons for screening at 45 Motivations • Rising incidence in age <50 • No current efforts in age < 50 • May boost screening overall Potential Shortcomings • No strong data to support • Possible diversion of resources • Additional 21 million to screen between age 45-49 • May widen inequities in screening • Cost • Insurance coverage Liang et al, Gastro, 2018. Imperiale et al, CGH, 2018.
  • 27. drfolamay gFOBT CT Colonography Fecal Immunochemical Test (FIT) FIT-DNA (Cologuard) Stool-based strategies Direct-visualization techniques Flexible Sigmoidoscopy Colonoscopy Screening tests Serology Capsule
  • 28. drfolamay Colonoscopy • Performed in a hospital or medical clinic • Requires bowel preparation • Gastroenterologist uses a “colonoscope,” a long flexible tube with a light at the end • Requires conscious sedation or monitored anesthesia care • Examines the walls of the colon (20-30 minutes) • Risks are very small (1:1000) and include bleeding, infection, and colon injury • Considered the gold standard for finding colon cancer or precancerous polyps • If normal, repeated every 10 years
  • 29. drfolamay A proper colon prep is key!
  • 30. drfolamay Polyps can be hard to see
  • 31. drfolamay Barriers to screening colonoscopy Embarrassment Fear of discomfort Time off Work Insurance Concerns about Prep Access to endoscopist Fear of Sedation Out of pocket costs Need for escort
  • 32. drfolamay Fecal immunochemical test (FIT) • Second most common screening test • Stool-based test that can be performed at home • Tests the stool for small amounts of human blood which may be a sign of colon cancer • Low-risk screening option • Performed yearly to be effective • Two-step screening process
  • 33. drfolamay Abnormal follow-up after positive FIT Positive FIT Result Must have colonoscopy
  • 34. drfolamay Abnormal follow-up after positive FIT Up to 1 in 3 with abnormal FIT have a large polyp or colon cancer. Up to 1 in 10 with abnormal FIT have colon cancer.
  • 35. drfolamay gFOBT CT Colonography Fecal Immunochemical Test (FIT) FIT-DNA (Cologuard) Flexible Sigmoidoscopy Colonoscopy Serology Capsule
  • 36. drfolamay • Tests stool for 11 pre-cancer and cancer biomarkers • Includes test for human hemoglobin (i.e. DNA+FIT) • 3-year screening interval (proposed) • Limitations: • Very few studies • No data to support 3-year interval • High false positive rate • High failure to complete rate • Not always covered by insurance Multitarget stool DNA (Cologuard)
  • 37. drfolamay gFOBT CT Colonography Fecal Immunochemical Test (FIT) FIT-DNA (Cologuard) Flexible Sigmoidoscopy Colonoscopy Serology Capsule
  • 38. drfolamay gFOBT CT Colonography Fecal Immunochemical Test (FIT) FIT-DNA (Cologuard) Flexible Sigmoidoscopy Colonoscopy Serology Capsule
  • 39. drfolamay CT Colonography • CT or “CAT Scan” that provides a 2-D and 3-D image of the colon. • Requires a bowel preparation and insufflation with air or carbon dioxide. • Requires colonoscopy if polyps are found • Does not detect small polyps well • May result in further unnecessary testing and costs due to unexpected findings (25%-80% cases).
  • 40. drfolamay gFOBT CT Colonography Fecal Immunochemical Test (FIT) FIT-DNA (Cologuard) Flexible Sigmoidoscopy Colonoscopy Serology Capsule
  • 41. drfolamay “First Tier” tests Colonoscopy Every 10 years Fecal Immunochemical Test (FIT) annually MSTF. 2018.
  • 42. drfolamay Despite strong evidence for screening and guidelines, one in three Americans is unscreened
  • 43. drfolamay Behavioral Risk Factor Surveillance System (BRFSS), 2012. Screening* (%) Among US Adults Age 50-75 Colorectal cancer screening uptake PercentPopulationScreened Year 37.1% 55.0% 64.5% 65.1% 66.2% 67.3%
  • 44. Patient-Level Factors Knowledge Beliefs Health Literacy Education Income Insurance Access to care Comorbidity Cancer fatalism Fear Provider-Level Factors Health care setting Knowledge of guidelines Practices Recommendation to screen System-Level Factors Reminder systems Access to providers Colonoscopy capacity Care coordination Smedley et al. IOM, 2003. So why is screening so difficult? drfolamay
  • 45. National campaign to increase screening • National Colorectal Cancer Roundtable campaign • In 2014, established goal of ”80% by 2018” • Endorsed by over 700 organizations & institutions • Renewed in 2018 as “80% in every community” • Targeted efforts and funding to improve screening in low participation populations drfolamay
  • 46. Rates decreasing over time Surveillance, Epidemiology, and End Results Program 9; 1975-2013. drfolamay
  • 47. Improving from here • Increase participation in screening • Know your family history • “Surveillance” for individuals with polyps • Follow screening intervals • Survivors need to continue colonoscopies • Year 1  Year 4  Year 9 drfolamay
  • 48. Colonoscopy for survivors Kahi et al. AJG. 2016. Colorectal cancer diagnosis Colonoscopy before surgery (or 3-6 mo post) Colonoscopy at 1 year Surgical resection Colonoscopy 3 years later Colonoscopy every 5 years *If rectal cancer: May need rectal ultrasound every 3-6 months as well (2-3 years) drfolamay
  • 49. drfolamay And are there additional ways to minimize risk?
  • 50. drfolamay Colon cancer risk factors Risk Factors You Can Change • Diet • Physical inactivity • Obesity • Type 2 diabetes • Tobacco use • Heavy alcohol use Risk Factors You Can Not Change • Age • Male gender • Race (African-Americans) • Personal history of polyps • Family history of polyps or cancer • Inflammatory bowel disease (IBD) • Inherited polyp syndromes
  • 51. drfolamay Modifying your diet • Minimize processed meats: • Ham, bacon, hot dogs, raw sausages (salami), bologna, blood sausage, pate, meat spreads, cold cuts, canned meats, corned beef • Minimize red meats: • Beef, pork, lamb, goat • Increase intake of: • Whole grains, fiber, fruit, non-starchy vegetables, vitamin C-rich foods, fish, vitamin D Slide credit: UCLA Digestive Health Nutrition Program
  • 52. drfolamay Other lifestyle changes • Increase physical activity • Drink alcohol in moderation • Maximum of 2 drinks/day for men; 1 drink/day for women • Maximum 14 units/week for men and women • Avoid tobacco
  • 53. In summary • Screening for colon cancer is effective • Screening works by removing polyps and finding cancers early • There are many effective screening options so pick the one that is best for you • We can all help educate family and loved ones about colon cancer risk and screening drfolamay
  • 55.
  • 56. Q & A SNAP A #STRONGARMSELFIE In 2018, up to $55,000 will be donated thanks to our sponsors: Bayer, Fujifilm, Myriad Genetics and Taiho Oncology! Flex a “strong arm” & post it to Twitter or Instagram using the hashtag #StrongArmSelfie
  • 57. CONTACT US CALL TOLL FREE 1.877.427.2111

Editor's Notes

  1. You can see the rate of young onset CRC increasing on the top and the rate of traditional CRC decreasing on the bottom. However, what I want to draw your attention to is the scale of the y axis. For young patients, we are talking about an increase from 5.9 to 6.6 new cases per 100,000, which is a small clinical impact compared to traditional onset CRC, where we are talking about 150 cases per 100,000
  2. --Can find very early colon cancers and remove polyps, even before they turn in to cancer Performed in a hospital or medical clinic Requires bowel preparation Takes approximately 20-30 minutes Gastroenterologist uses a “colonoscope,” a long flexible tube with a light at the end. Examines the walls of the colon Requires conscious sedation or monitored anesthesia care. Risks are very small (1:1000) and include bleeding, infection, and colon injury. Considered the gold standard for finding colon cancer or precancerous polyps. If normal, only repeated every 10 years.
  3. -Colon cancer cells and polyps have abn cellsCellular exfoliation of DNA ….shed continuosly -Fit portion is OC-FIT CHECK -Approved for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool -Cost $500-700 ($216 per year because Q3)
  4. Septin 9 not recommended
  5. Lots of work Give examples of studies
  6. -80% in Every Community is an NCCRT initiative that continues the progress and commitment from 80% by 2018, and reemphasizes our dedication to partnership, collective action, and the pooling of resources to reach 80% colorectal cancer screening rates nationally. Our shared efforts are working, community health clinics, health plans, employers, counties, and others are seeing 80% screening rates and higher. -14 million colonocospies done per year in US Also recent national efforts A lot of recent attention to low screening rates CDC and other agencies want to know why screening rates so low when we have a way to actually prevent cancer and death from cancer Campaign launched . . . impossible to reach our population-wide goal unless we address low screening rates in all populations Need for help to improve screening rates in community health centers
  7. -OVERALL, CRC incidence and mortality from CRC have improve over time. -We have seen a decline in incidence in both men and women since 1990s. Mortiality in both sexes has also trended downward But we can do even better. But we need to continue to improve. We can do even better
  8. -very important for survivors to get surveillance
  9. -One alcoholic drink-equivalent is described as containing 14 g (0.6 fl oz) of pure alcohol.[1] The following are reference beverages that are one alcoholic drink-equivalent: 12 fluid ounces of regular beer (5% alcohol), 5 fluid ounces of wine (12% alcohol), or 1.5 fluid ounces of 80 proof distilled spirits (40% alcohol).[2]